Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
Clinical trial NCT00053508 · TERMINATED
Trial details
- NCT number
- NCT00053508
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2003-03-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.